1. Home
  2. SVRA vs GUT Comparison

SVRA vs GUT Comparison

Compare SVRA & GUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • GUT
  • Stock Information
  • Founded
  • SVRA 2007
  • GUT 1999
  • Country
  • SVRA United States
  • GUT United States
  • Employees
  • SVRA N/A
  • GUT N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • GUT Trusts Except Educational Religious and Charitable
  • Sector
  • SVRA Health Care
  • GUT Finance
  • Exchange
  • SVRA Nasdaq
  • GUT Nasdaq
  • Market Cap
  • SVRA 528.3M
  • GUT 475.6M
  • IPO Year
  • SVRA N/A
  • GUT N/A
  • Fundamental
  • Price
  • SVRA $2.28
  • GUT $5.47
  • Analyst Decision
  • SVRA Buy
  • GUT
  • Analyst Count
  • SVRA 7
  • GUT 0
  • Target Price
  • SVRA $7.57
  • GUT N/A
  • AVG Volume (30 Days)
  • SVRA 2.5M
  • GUT 176.3K
  • Earning Date
  • SVRA 05-13-2025
  • GUT 01-01-0001
  • Dividend Yield
  • SVRA N/A
  • GUT 10.93%
  • EPS Growth
  • SVRA N/A
  • GUT N/A
  • EPS
  • SVRA N/A
  • GUT N/A
  • Revenue
  • SVRA N/A
  • GUT N/A
  • Revenue This Year
  • SVRA N/A
  • GUT N/A
  • Revenue Next Year
  • SVRA N/A
  • GUT N/A
  • P/E Ratio
  • SVRA N/A
  • GUT N/A
  • Revenue Growth
  • SVRA N/A
  • GUT N/A
  • 52 Week Low
  • SVRA $1.89
  • GUT $4.60
  • 52 Week High
  • SVRA $5.11
  • GUT $7.38
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 36.20
  • GUT 62.61
  • Support Level
  • SVRA $1.89
  • GUT $5.37
  • Resistance Level
  • SVRA $3.18
  • GUT $5.48
  • Average True Range (ATR)
  • SVRA 0.21
  • GUT 0.06
  • MACD
  • SVRA -0.11
  • GUT 0.01
  • Stochastic Oscillator
  • SVRA 29.77
  • GUT 85.00

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About GUT Gabelli Utility Trust (The)

Gabelli Utility Trust operates as a diversified closed-end investment management company. The fund's primary objective is the long-term growth of capital and income. To achieve its objective, the fund may invest its assets in common stocks and other securities of foreign and domestic companies involved in providing products, services, or equipment for the generation or distribution of electricity, gas, & water; and telecommunications services or infrastructure operations. It invests in various sectors, of which Electric Integrated, Water, Telecommunications, and U.S. Government Obligations and others.

Share on Social Networks: